Slawin Kevin M.
Insider CIK 1626808 · BLCM Chief Technology Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2017-06-14 | 2017-06-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2017-02-07 | 2017-02-09 | 30,000 | $12.54 | $376.2K | 294,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-12-15 | 2016-12-19 | 30,000 | $15.45 | $463.5K | 324,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-23 | 2016-09-23 | 11,258 | $20.12 | $226.5K | 84,206 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-23 | 2016-09-23 | 11,958 | $20.11 | $240.5K | 354,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-21 | 2016-09-23 | 100 | $20.04 | $2.0K | 95,464 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-21 | 2016-09-23 | 100 | $20.04 | $2.0K | 366,940 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-20 | 2016-09-20 | 100 | $20.00 | $2.0K | 367,040 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-20 | 2016-09-20 | 300 | $20.00 | $6.0K | 95,564 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-19 | 2016-09-20 | 1,400 | $20.02 | $28.0K | 95,864 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-19 | 2016-09-20 | 1,206 | $20.01 | $24.1K | 367,140 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-16 | 2016-09-20 | 942 | $20.00 | $18.8K | 97,264 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-09-16 | 2016-09-20 | 636 | $20.00 | $12.7K | 368,346 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-08-15 | 2016-08-17 | 1,873 | $20.01 | $37.5K | 98,206 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-08-15 | 2016-08-17 | 34,127 | $19.27 | $657.6K | 100,079 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-08-15 | 2016-08-17 | 2,000 | $20.01 | $40.0K | 368,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-08-15 | 2016-08-17 | 29,000 | $19.27 | $558.8K | 370,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-07-27 | 2016-07-29 | 15,000 | $15.00 | $225.0K | 399,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-07-18 | 2016-07-19 | 2,719 | $13.99 | $38.0K | 134,206 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-07-15 | 2016-07-19 | 22,281 | $13.72 | $305.7K | 136,925 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-04-22 | 2016-04-26 | 25,000 | $11.43 | $285.8K | 159,206 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-04-22 | 2016-04-26 | 29,800 | $11.42 | $340.3K | 415,182 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2016-04-22 | 2016-04-26 | 200 | $11.89 | $2.4K | 414,982 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2016-01-04 | 2016-01-06 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-11-16 | 2015-11-18 | 4,000 | $20.65 | $82.6K | 398,066 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-11-16 | 2015-11-18 | 6,000 | $20.65 | $123.9K | 184,206 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-11-16 | 2015-11-18 | 14,000 | $20.65 | $289.1K | 444,981 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-07-15 | 2015-07-17 | 1,000 | $20.00 | $20.0K | 402,066 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-07-15 | 2015-07-17 | 1,500 | $20.00 | $30.0K | 163,008 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | S Sale | 2015-07-15 | 2015-07-17 | 3,500 | $20.00 | $70.0K | 458,981 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | A Award deriv | 2015-03-06 | 2015-03-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 109,328 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 29,130 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 61,933 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 71,063 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 25,277 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 26,633 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 95,283 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 17,311 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 38,889 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 110,514 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 28,737 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion deriv | 2014-12-23 | 2014-12-23 | 28,000 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 64,310 | — | $0 | 420,680 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 17,135 | — | $0 | 356,370 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 41,801 | — | $0 | 462,481 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 14,868 | — | $0 | 164,507 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 22,875 | — | $0 | 149,639 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | J Other | 2014-12-23 | 2014-12-23 | 2,537 | — | $0 | 115,198 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 10,182 | — | $0 | 112,661 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 15,666 | — | $0 | 102,479 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 65,008 | — | $0 | 86,813 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 16,904 | — | $0 | 21,805 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 36,431 | — | $0 | 403,066 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 56,048 | — | $0 | 366,635 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | C Conversion | 2014-12-23 | 2014-12-23 | 16,470 | — | $0 | 310,587 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 25,277 | — | $0 | 14,868 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 25,277 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 17,311 | — | $0 | 10,182 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 17,311 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 71,063 | — | $0 | 41,801 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 61,933 | — | $0 | 0 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 61,933 | — | $0 | 36,431 | SEC↗ |
| BLCM BELLICUM PHARMACEUTICALS, | X Exercise deriv | 2014-12-17 | 2014-12-19 | 71,063 | — | $0 | 0 | SEC↗ |